<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-08-06 - US into late-stage clin&#xAD;i&#xAD;cal tri&#xAD;als of an&#xAD;ti&#xAD;body treat&#xAD;ment</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200806/281745566730736" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>US into late-stage clin&#xAD;i&#xAD;cal tri&#xAD;als of an&#xAD;ti&#xAD;body treat&#xAD;ment</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200806/textview" title="The Straits Times - 2020-08-06"><time>2020-08-06</time></a>
        - <span>TOP OF THE NEWS</span>
        - <span role="byline"></span>
    </section>

    <p>WASH­ING­TON • The United States has be­gun late-stage clin­i­cal tri­als of a drug for­mu­lated to fight Covid-19, of­fi­cials said on Tues­day.</p>
    <p>The medicine is an an­ti­body against the new coron­avirus called LY-CoV555, which was iden­ti­fied in the blood sample of a re­cov­ered pa­tient by Canada’s Abcellera Bi­o­log­ics. It was then de­vel­oped syn­thet­i­cally for mass pro­duc­tion by US-based Lilly Re­search Lab­o­ra­to­ries in part­ner­ship with Abcellera.</p>
    <p>The phase three trial will ini­tially en­rol some 300 vol­un­teers around the world who have been hospitalis­ed with mild to mod­er­ate Covid-19 with fewer than 13 days of symp­toms.</p>
    <p>Each will be as­signed ei­ther the medicine, which will be in­jected in­tra­venously, or a placebo.</p>
    <p>Pa­tients will also re­ceive stan­dard care for Covid-19, in­clud­ing the an­tivi­ral remde­sivir.</p>
    <p>The new phase three trial could ex­pand to up to 1,000 peo­ple, in­clud­ing the more se­verely ill, if LY-CoV555 ap­pears safe and ef­fec­tive af­ter the fifth day.</p>
    <p>The trial’s main goal is the pa­tients’ sus­tained re­cov­ery for 14 days af­ter re­lease from the hos­pi­tal.</p>
    <p>At the same time, the new drug is also be­ing tested on peo­ple with mild to mod­er­ate symp­toms of Covid-19 who have not been hospitalis­ed, as part of a par­al­lel mid­dle-stage trial also an­nounced on Tues­day.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
